Manning & Napier Group, LLC Abb Vie Inc. Transaction History

Manning & Napier Group, LLC

$8.76 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $46.4 Million - $51.6 Million	-440,566 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $868,629 - $956,256	8,491 Added 1.97%	440,566 $47.7 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $2.25 Million - $3.04 Million	-27,966 Reduced 6.08%	432,075 $46.3 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $537,968 - $631,397	6,262 Added 1.38%	460,041 $40.3 Million
Q2 2020 Jul 10, 2020	SELL	$73.37 - $98.18 $247,403 - $331,062	-3,372 Reduced 0.74%	453,779 $44.6 Million
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $178,858 - $271,171	-2,773 Reduced 0.6%	457,151 $34.8 Million
Q4 2019 Jan 10, 2020	BUY	$72.13 - $90.25 $2.77 Million - $3.46 Million	38,385 Added 9.11%	459,924 $40.7 Million
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $141,705 - $170,370	2,250 Added 0.54%	421,539 $31.9 Million
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $2.63 Million - $3.36 Million	39,969 Added 10.54%	419,289 $30.5 Million
Q1 2019 Apr 10, 2019	BUY	$77.14 - $90.79 $6.45 Million - $7.59 Million	83,583 Added 28.26%	379,320 $30.6 Million
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $709,836 - $875,419	9,118 Added 3.18%	295,737 $27.3 Million
Q3 2018 Oct 10, 2018	BUY	$88.91 - $98.84 $1.86 Million - $2.07 Million	20,976 Added 7.9%	286,619 $27.1 Million
Q2 2018 Jul 13, 2018	SELL	$89.78 - $106.23 $898,069 - $1.06 Million	-10,003 Reduced 3.63%	265,643 $24.6 Million
Q1 2018 May 01, 2018	BUY	$92.01 - $123.21 $3.76 Million - $5.04 Million	40,902 Added 17.42%	275,646 $26.1 Million
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $21 Million - $23.1 Million	234,744	234,744 $22.7 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Account